These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Paraneoplastic Neurological Syndromes: Transitioning Between the Old and the New. Gastaldi M; Scaranzin S; Pietro B; Lechiara A; Pesce G; Franciotta D; Lorusso L Curr Oncol Rep; 2022 Oct; 24(10):1237-1249. PubMed ID: 35476177 [TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic autonomic neuropathies and GI dysmotility. Golden EP; Vernino S Handb Clin Neurol; 2024; 200():275-282. PubMed ID: 38494282 [TBL] [Abstract][Full Text] [Related]
7. Immune-mediated encephalopathies with an emphasis on paraneoplastic encephalopathies. Pruitt AA Semin Neurol; 2011 Apr; 31(2):158-68. PubMed ID: 21590621 [TBL] [Abstract][Full Text] [Related]
8. [Neurological syndromes, encephalitis]. Yamamoto T; Tsuji S Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100 [TBL] [Abstract][Full Text] [Related]
9. Autoimmune Neurology of the Central Nervous System. Tobin WO; Pittock SJ Continuum (Minneap Minn); 2017 Jun; 23(3, Neurology of Systemic Disease):627-653. PubMed ID: 28570322 [TBL] [Abstract][Full Text] [Related]
10. Autoimmune and paraneoplastic neurological disorders: A review of relevant neuroimaging findings. Akkus S; Elkhooly M; Amatya S; Shrestha K; Sharma K; Kagzi Y; Khan E; Gupta R; Piquet AL; Jaiswal S; Wen S; Tapia M; Samant R; Sista SR; Sriwastava S J Neurol Sci; 2023 Nov; 454():120830. PubMed ID: 37856996 [TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic neurological syndrome: growing spectrum and relevance. Ganaraja VH; Rezk M; Dubey D Neurol Sci; 2022 Jun; 43(6):3583-3594. PubMed ID: 35460452 [TBL] [Abstract][Full Text] [Related]
13. Changing landscape in the field of paraneoplastic neurology: Personal perspectives over a 35-year career. Dalmau J Handb Clin Neurol; 2024; 200():11-32. PubMed ID: 38494272 [TBL] [Abstract][Full Text] [Related]
14. Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery. Segal Y; Zekeridou A Curr Opin Neurol; 2024 Jun; 37(3):295-304. PubMed ID: 38533672 [TBL] [Abstract][Full Text] [Related]
15. Kelch-like protein 11 antibody-associated paraneoplastic neurological syndrome: A state-of-the-art review. Li EC; Lai QL; Cai MT; Zheng Y; Fang GL; Fang W; Du BQ; Shen CH; Ding MP; Zhang YX Clin Immunol; 2022 Aug; 241():109074. PubMed ID: 35809856 [TBL] [Abstract][Full Text] [Related]
16. Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes. Blaes F Expert Rev Neurother; 2021 Jun; 21(6):675-686. PubMed ID: 33960258 [No Abstract] [Full Text] [Related]
17. Updates in the Management of Paraneoplastic Syndrome. Verma N; Jaffer MH; Kolli AS; Mokhtari S Semin Neurol; 2024 Feb; 44(1):36-46. PubMed ID: 38183975 [TBL] [Abstract][Full Text] [Related]
18. [Paraneoplastic Disorders of the Central Nervous System]. Kimura A Brain Nerve; 2021 May; 73(5):620-630. PubMed ID: 34006696 [TBL] [Abstract][Full Text] [Related]